BioSpace News Archive

Policy

DOJ Closes Investigation of Sinovac

Sinovac Biotech Ltd. today announced that the U.S. Department of Justice (“DOJ”) has closed its investigation, with no charges, into possible violations of the Foreign Corrupt Practices Act related to allegations that certain Sinovac employees made improper payments to Chinese government officials.

September 17, 2018
·
3 min read
Policy

Neptune Receives Confirmation of Readiness Letter from Health Canada

Key milestone toward approval of application to become a Licensed Producer achieved

September 17, 2018
·
4 min read
Drug Development

Realm Therapeutics Provides Corporate Update and Hires Advisor to Support Strategic Review including Formal Sale Process

Realm Therapeutics plc today provides a corporate update following the August 14, 2018 announcement of top-line results of the Company’s Phase 2 trial of PR022 in Atopic Dermatitis

September 17, 2018
·
10 min read
Drug Development

Acerus Announces Publication of Manuscript Reporting Early Data from Partner-Sponsored Natesto® Spermatogenesis Study

Early Data Suggests Sperm Concentration, Motility, and Total Motile Sperm Count Remain Within Normal Ranges in Hypogonadal Men Taking Natesto®

September 17, 2018
·
5 min read
Business

AbbVie to Host Third-Quarter 2018 Earnings Conference Call

Friday, November 2 2018, AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time

September 17, 2018
·
1 min read
Business

ChineseInvestors.com, Inc. Expands its Physical Presence With the Announcement of its New Sales Office Location in Richmond, British Columbia, Canada

Offering its Innovative Financial Subscription and Educational Services to Chinese Globally

September 17, 2018
·
3 min read
Biotech Beach

Halozyme Announces Approval Of Subcutaneous Formulation Of Trastuzumab (Herceptin®) In Canada

This is a co-formulation with Halozyme’s proprietary recombinant human hyaluronidase enzyme.

September 17, 2018
·
3 min read
Drug Development

CartiHeal Performs First Hungarian Case in the Agili-C™ Implant IDE Multinational Pivotal Study

Successful enrollment of the first Hungarian patient in the Agili-C IDE pivotal study.

September 17, 2018
·
2 min read
Drug Development

New study results provide evidence that Ofev® (nintedanib) slows progression of IPF beyond four years with consistent safety

- INPULSIS®-ON study indicates safety and efficacy of Ofev® (nintedanib) are maintained over the long term and consistent with prior findings from INPULSIS trials

September 17, 2018
·
9 min read
Deals

BioTime Updates Timeline for Distribution of AgeX Shares to BioTime Shareholders

Regulatory Approvals In-Process; New Record Date to be Set Shortly

September 17, 2018
·
8 min read